Deng‐Yn Lin

1.2k total citations · 1 hit paper
9 papers, 953 citations indexed

About

Deng‐Yn Lin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Deng‐Yn Lin has authored 9 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Deng‐Yn Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (3 papers). Deng‐Yn Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (3 papers). Deng‐Yn Lin collaborates with scholars based in Taiwan, Germany and South Korea. Deng‐Yn Lin's co-authors include Ann‐Lii Cheng, Silvana Lanzalone, Éric Raymond, Liqiang Yang, Susan Pitman Lowenthal, Shukui Qin, Guido Poggi, Hyun Cheol Chung, María José Lechuga and Masatoshi Kudo and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Journal of Hepatology.

In The Last Decade

Deng‐Yn Lin

9 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial

2013 586 citations Ann‐Lii Cheng, Yoon‐Koo Kang et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Deng‐Yn Lin

Since Specialization

Citations

This map shows the geographic impact of Deng‐Yn Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deng‐Yn Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deng‐Yn Lin more than expected).

Fields of papers citing papers by Deng‐Yn Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deng‐Yn Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deng‐Yn Lin. The network helps show where Deng‐Yn Lin may publish in the future.

Co-authorship network of co-authors of Deng‐Yn Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Deng‐Yn Lin. A scholar is included among the top collaborators of Deng‐Yn Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deng‐Yn Lin. Deng‐Yn Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma 2018 ·Liver Cancer ·Chia-Jui Yen, Tae‐You Kim, Yin‐Hsun Feng, Yee Chao, Deng‐Yn Lin, Baek‐Yeol Ryoo, Dennis Huang, David Schnell, (unknown), Arsène‐Bienvenu Loembé, Ann‐Lii Cheng	21
2	High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities 2013 ·Oncology Letters ·(unknown), Ngan‐Ming Tsang, Shi‐Ming Lin, Deng‐Yn Lin, Jau‐Min Lien, (unknown), Wei‐Ting Chen, Chen Wy, Ji-Hong Hong	9
3	Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial breakdown → 2013 ·Journal of Clinical Oncology ·Ann‐Lii Cheng, Yoon‐Koo Kang, Deng‐Yn Lin, Joong‐Won Park, Masatoshi Kudo, Shukui Qin, Hyun Cheol Chung, Xiangqun Song, Jianming Xu, Guido Poggi, Masao Omata, Susan Pitman Lowenthal, Silvana Lanzalone, Liqiang Yang, María José Lechuga, Éric Raymond	586
4	Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection 2011 ·Annals of Surgery ·Li‐Tzong Chen, Miin-Fu Chen, (unknown), Po‐Huang Lee, Long‐Bin Jeng, Deng‐Yn Lin, Cheng-Chung Wu, (unknown), Chao‐Long Chen, Wei‐Chen Lee, Gar-Yang Chau, (unknown), (unknown), Chin‐Fu Hsiao, Jacqueline Whang‐Peng, Pei‐Jer Chen	110
5	Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage 2009 ·Journal of Hepatology ·Chun‐Jen Liu, Po‐Huang Lee, Deng‐Yn Lin, Cheng-Chung Wu, Long‐Bin Jeng, Pin-Wen Lin, (unknown), Wei‐Chen Lee, Hong-Zen Yeh, Ming‐Chih Ho, Sheng‐Shun Yang, Ching-Chih Lee, Ming‐Chin Yu, Rey‐Heng Hu, Cheng‐Yuan Peng, (unknown), (unknown), Pei‐Jer Chen	121
6	Cytologic Changes in Small Hepatocellular Carcinomas After Radiofrequency Ablation 2002 ·Acta Cytologica ·Shi-Ming Lin, (unknown), Deng‐Yn Lin, (unknown), Chun‐Jung Lin, Chao‐Wei Hsu, (unknown), Cheng‐Yuan Peng	8
7	Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study 1996 ·Journal of Hepatology ·I-Shyan Sheen, Yun-Fan Liaw, Deng‐Yn Lin, Chia‐Ming Chu	33
8	Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection 1991 ·Gastroenterologia Japonica ·Yun‐Fan Liaw, Rong‐Nan Chien, I‐Shyan Sheen, Deng‐Yn Lin, (unknown), Chia‐Ming Chu	11
9	Metastatic Septic Endophthalmitis in Pyogenic Liver Abscess 1988 ·Journal of Clinical Gastroenterology ·(unknown), Deng‐Yn Lin, Yun‐Fan Liaw	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact